The Yale Child Study Center is an internationally recognized center of innovation in child and family mental health, dedicated to promoting healthy development and psychological well-being across the lifespan. We care for children and adolescents whose families are concerned about their child’s development and behavior. Common concerns include developmental delays, behaviors or worries that interfere with their child’s life, isolation and fear of school, and defiant and difficult behavior. Our first job is to listen. As we begin to understand the family and child, we will guide our patients through the evaluation, diagnosis, and treatment process. We provide office and home-based interventions as well as telehealth services, and we work with as many people involved in your child’s growth as possible, including parents, teachers and pediatricians. Above all, we care about your child’s development and your family’s well-being. We will use every means available—and maybe even invent some new ones—to help the child and their family. We are committed to working with every family to help them understand and address their child’s and family’s needs. Our interdisciplinary teams use up-to-date science to evaluate and then work with the family to develop a comprehensive treatment recommendations. Our treatment may include (one-on-one or group) therapy, family therapy, and parent-centered approaches and collaboration with schools. When appropriate, our providers will discuss the use of medication, providing detailed information so parents can make an informed decision. Many of our patients improve and thrive without medication, and for others it is a valuable part of their treatment. At the Yale Child Study Center, we are pioneering many treatments including approaches that help parents improve disruptive anger and aggression in children with autism and other developmental disorders. We are also developing new ways to help children overcome anxieties that may limit their daily lives, and treatment approaches designed to lessen the impact of an overwhelming event on the child and family. Finally, we work directly with parents around their own concerns about their roles as parents.

Internationally known for clinical excellence and cutting-edge research, we provide promising treatment options for adult and pediatric patients. Our program was one of the nation's first, and has evolved into one of the most active and advanced in the world.Yale is internationally recognized as a leader in innovative treatment for medically intractable and new onset epilepsy. We treat patients in outpatient settings, at a six-bed adult epilepsy monitoring unit, a two-bed pediatric epilepsy monitoring unit, and a technologically advanced operating suite. We are also equipped with state-of-the-art technology for continuous brain and video monitoring of seizures in children and infants. We evaluate patients in phases to precisely determine concordance of electrophysiology, cognitive testing, history, as well as physical and neurological examination with advanced imaging, using MRI, SPECT, and PET techniques. Doctors treat each surgical patient as an individual, determining which procedure or combination of procedures is appropriate.

Yale Psychiatry is the largest provider of psychiatric services in Connecticut, and the top National Institutes of Health-supported Department of Psychiatry in the United States. We are dedicated to adding to the body of knowledge in the field, and improving treatments for psychiatric disorders that span all ages. This includes helping people cope with major life events or medical illnesses, behavioral problems associated with personality disorder or addiction, mood and psychotic disorders, and dementia. Yale investigators have pioneered new treatments for nearly every psychiatric disorder. Our research programs have produced breakthroughs in areas as diverse as molecular neuroscience, genetics, translational neuroscience, neuroimaging, psychopharmacology, psychotherapy, rehabilitation, health services, forensic psychiatry, epidemiology, and health policy. Today, our clinicians are at the forefront of social, pharmacological, psychological, rehabilitative, and neurostimulation treatments. Through clinical trials, our interventional psychiatry service delivers high-impact treatments, including ECT (electroconvulsive therapy) and ketamine, for patients with treatment-resistant symptoms of depression. Our clinical programs are interwoven with our research efforts. We host programs that specialize in the major mental diseases and substance abuse treatment at three major institutions: Connecticut Mental Health Center, the Veterans Affairs Connecticut Healthcare System, and the Yale New Haven Psychiatric Hospital. We also provide increased psychiatry support for Smilow Cancer Hospital in areas such as smoking cessation.